Periodic Reporting for period 1 - Everfill (Improving the Quality of Life of Millions through the Revolutionary Approach in Dermal Regeneration Care)
Reporting period: 2019-05-01 to 2019-09-30
Considering high costs and duration of the pre-commercial phase, which includes clinical trials and regulatory clearance, it was especially important to make a proper choice of a first strategic focus for the company, so that limited resources are not spread in too many application areas. Although each of potential market segments has a huge market potential, there are differences in time-to-market and required funding. So our main objective was to conduct a thorough market segmentation analysis to define the market entry strategy and the commercialization roadmap.